AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
175.18
-2.71 (-1.52%)
Jun 18, 2026, 2:38 PM EDT - Market open
AstraZeneca Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 279,891 | 544,369 | 403,142 | 416,839 | 422,228 | 358,996 | |
Market Cap Growth | 25.71% | 35.03% | -3.29% | -1.28% | 17.61% | 35.39% |
Enterprise Value | 306,677 | 568,302 | 427,868 | 439,522 | 445,076 | 383,398 |
Last Close Price | 175.18 | 175.50 | 130.00 | 134.45 | 136.22 | 115.85 |
PE Ratio | 26.94 | 53.67 | 57.78 | 70.58 | 129.12 | 2896.25 |
PS Ratio | 4.63 | 9.27 | 7.46 | 9.10 | 9.52 | 9.59 |
PB Ratio | 5.91 | 11.19 | 9.88 | 10.65 | 11.40 | 9.14 |
P/FCF Ratio | 24.78 | 46.27 | 40.57 | 46.40 | 48.44 | 73.69 |
P/OCF Ratio | 19.68 | 37.35 | 33.99 | 40.29 | 43.05 | 60.20 |
EV/Sales Ratio | 5.07 | 9.68 | 7.91 | 9.59 | 10.04 | 10.25 |
EV/EBITDA Ratio | 15.31 | 29.18 | 25.63 | 32.37 | 48.18 | 50.54 |
EV/EBIT Ratio | 20.51 | 41.35 | 42.77 | 53.65 | 118.47 | 363.07 |
EV/FCF Ratio | 27.16 | 48.30 | 43.06 | 48.92 | 51.06 | 78.69 |
Debt / Equity Ratio | 0.55 | 0.54 | 0.68 | 0.59 | 0.64 | 0.74 |
Debt / EBITDA Ratio | 1.69 | 1.52 | 1.82 | 2.11 | 3.17 | 4.06 |
Debt / FCF Ratio | 3.00 | 2.52 | 3.05 | 3.19 | 3.35 | 6.32 |
Net Debt / Equity Ratio | 0.55 | 0.49 | 0.60 | 0.58 | 0.62 | 0.62 |
Net Debt / EBITDA Ratio | 1.30 | 1.23 | 1.48 | 1.67 | 2.47 | 3.21 |
Net Debt / FCF Ratio | 2.32 | 2.03 | 2.48 | 2.52 | 2.62 | 5.01 |
Asset Turnover | 0.53 | 0.54 | 0.53 | 0.46 | 0.44 | 0.43 |
Inventory Turnover | 1.69 | 1.80 | 1.91 | 1.63 | 1.81 | 1.91 |
Quick Ratio | 0.67 | 0.68 | 0.67 | 0.59 | 0.64 | 0.71 |
Current Ratio | 0.91 | 0.94 | 0.93 | 0.82 | 0.86 | 1.16 |
Return on Equity (ROE) | 21.63% | 22.84% | 17.59% | 15.64% | 8.63% | 0.42% |
Return on Assets (ROA) | 10.10% | 10.40% | 7.90% | 7.16% | 4.90% | -0.53% |
Return on Invested Capital (ROIC) | 12.44% | 13.01% | 9.66% | 8.56% | 6.04% | -0.68% |
Return on Capital Employed (ROCE) | 17.36% | 17.22% | 13.63% | 11.64% | 4.91% | 1.63% |
Earnings Yield | 3.71% | 1.86% | 1.73% | 1.42% | 0.77% | 0.03% |
FCF Yield | 4.03% | 2.16% | 2.46% | 2.16% | 2.06% | 1.36% |
Dividend Yield | 1.83% | 0.91% | 1.15% | 1.08% | 1.03% | 1.17% |
Payout Ratio | 48.19% | 48.62% | 65.80% | 75.25% | 132.72% | 3442.86% |
Buyback Yield / Dilution | 0.08% | 0.06% | -0.06% | -0.13% | -9.32% | -8.68% |
Total Shareholder Return | 1.91% | 0.98% | 1.08% | 0.95% | -8.29% | -7.51% |